Literature DB >> 20874798

Telomere length is a prognostic factor for overall survival in colorectal cancer.

C Valls1, C Piñol, J M Reñé, J Buenestado, J Viñas.   

Abstract

AIM: The aim of this study was to determine whether telomere length is an independent prognostic factor for the prevention and survival of colorectal cancer.
METHOD: Terminal restriction fragment (TRF) length was determined by Southern blot in tumours and paired normal tissue samples from 147 patients with sporadic colorectal cancer who had undergone surgery. The TRF length ratio (TRFLR) was determined as the ratio between the length of the patient's tumour and normal tissue.The classification and regression tree technique was used to determine optimal cut-off values (≤ 1 or > 1).
RESULTS: Mean TRF length was 6.79 Kbp (1.19-13.99) in tumour tissue and 7.81 Kbp (3.63-15.70) in normal mucosa (P < 0.001). Mean TRFLR was 0.88. Telomere length and telomere length ratio were not correlated with any clinicopathological factors. In univariate analysis, overall survival was related to N stage (lymph node +/-; P = 0.002), TNM classification (P = 0.019) and TRFLR (≤ 1 or > 1; P = 0.014). In multivariate analysis, overall survival was significantly associated with TRFLR and N stage. Colorectal cancer patients with TRFLR ≤ 1 and negative lymph node involvement had a higher overall survival rate.
CONCLUSION: Telomere length ratio is an independent prognostic factor for survival in colorectal cancer patients, and the telomere lengths in the normal and tumour mucosa of the same patient present with parallel behaviour.
© 2011 The Authors. Colorectal Disease © 2011 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20874798     DOI: 10.1111/j.1463-1318.2010.02433.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  19 in total

1.  Telomere shortening in non-tumorous and tumor mucosa is independently related to colorectal carcinogenesis in precancerous lesions.

Authors:  Won-Jin Park; Sung Uk Bae; Yu-Ran Heo; Soo-Jung Jung; Jae-Ho Lee
Journal:  Int J Mol Epidemiol Genet       Date:  2017-11-01

2.  Genetic and lifestyle influence on telomere length and subsequent risk of colon cancer in a case control study.

Authors:  Andrew J Pellatt; Roger K Wolff; Abbie Lundgreen; Richard Cawthon; Martha L Slattery
Journal:  Int J Mol Epidemiol Genet       Date:  2012-08-31

Review 3.  Telomeres, telomerase and colorectal cancer.

Authors:  Roberta Bertorelle; Enrica Rampazzo; Salvatore Pucciarelli; Donato Nitti; Anita De Rossi
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

Review 4.  Telomeres and telomerase in the clinical management of colorectal cancer.

Authors:  C Piñol-Felis; T Fernández-Marcelo; J Viñas-Salas; C Valls-Bautista
Journal:  Clin Transl Oncol       Date:  2016-10-19       Impact factor: 3.405

5.  Leukocyte telomere length: a novel biomarker to predict the prognosis of glioma patients.

Authors:  Yibing Chen; Yousheng Wu; Xiaojun Huang; Ping Qu; Gang Li; Tianbo Jin; Jinliang Xing; Shiming He
Journal:  J Cancer Res Clin Oncol       Date:  2015-02-22       Impact factor: 4.553

6.  Depressive symptoms and shorter survival in lung cancer: the role of leukocyte telomere length.

Authors:  Chelsea J Siwik; Elizabeth Cash; Sandra E Sephton
Journal:  Psychol Health       Date:  2022-03-03

7.  Association of circulating leukocyte telomere length with survival in patients with colorectal cancer.

Authors:  Svenja Pauleck; Biljana Gigic; Richard M Cawthon; Jennifer Ose; Anita R Peoples; Christy A Warby; Jennifer A Sinnott; Tengda Lin; Juergen Boehm; Petra Schrotz-King; Christopher I Li; David Shibata; Erin M Siegel; Jane C Figueiredo; Adetunji T Toriola; Martin Schneider; Alexis B Ulrich; Albrecht Hoffmeister; Cornelia M Ulrich; Sheetal Hardikar
Journal:  J Geriatr Oncol       Date:  2022-01-05       Impact factor: 3.929

Review 8.  Association between telomere length and survival in cancer patients: a meta-analysis and review of literature.

Authors:  Xinsen Xu; Kai Qu; Qing Pang; Zhixin Wang; Yanyan Zhou; Chang Liu
Journal:  Front Med       Date:  2016-05-16       Impact factor: 4.592

9.  Prognostic significance of telomerase-associated parameters in glioblastoma: effect of patient age.

Authors:  Daniela Lötsch; Bahil Ghanim; Magdalena Laaber; Gabriele Wurm; Serge Weis; Stefan Lenz; Gerald Webersinke; Josef Pichler; Walter Berger; Sabine Spiegl-Kreinecker
Journal:  Neuro Oncol       Date:  2013-02-07       Impact factor: 12.300

10.  The presence of telomere fusion in sporadic colon cancer independently of disease stage, TP53/KRAS mutation status, mean telomere length, and telomerase activity.

Authors:  Hiromi Tanaka; Matthew J Beam; Kevin Caruana
Journal:  Neoplasia       Date:  2014-10-23       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.